Singulair News
Business Highlights - Houston Chronicle
The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents per share, compared with a year-ago ...
Daily Briefing - Atlanta Journal Constitution
The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents per share, compared with a year-ago ...
Earnings Preview: Merck & Co. - Houston Chronicle
ANALYST TAKE: BMO Capital Markets analyst Robert Hazlett expects sales of Januvia and the asthma treatment Singulair to drive fourth-quarter profit, ...
Merck's Guidance A Relief (MRK) - 24/7 Wall St.
all 2 news articles
Four North Coast hoop shooters advance to regionals - Daily Astorian
The event sponsored by Singulair provides boys and girls, competing separately, a free opportunity to showcase their excellence in the basketball skills of ...
Amazon.com profit surges - Chicago Tribune
The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax incurred charges totaling $3.4 billion, or $1.55 a share. ...
Business News - AOL Canada
The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents per share, compared with a year-ago ...
Drug-name mix-ups hurt patients, getting worse - Reuters
... including cholesterol drug Lipitor, heart drugs Toprol and Norvasc, antidepressant Lexapro, stomach acid pill Nexium and asthma drug Singulair. ...
Winners at NBA/WNBA skills event announced - Sheboygan Press
More than 70 participants competed in the Jr. NBA/WNBA Skills Competition held last Saturday at South High, sponsored by Singulair and hosted by the ...
Winners at NBA/WNBA skills event announced - Sheboygan Press
More than 70 participants competed in the Jr. NBA/WNBA Skills Competition held last Saturday at South High, sponsored by Singulair and hosted by the ...
Singulair RSS Feed